These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1164 related items for PubMed ID: 17044040

  • 21. Androgen receptor-mediated repression of novel target genes.
    Prescott J, Jariwala U, Jia L, Cogan JP, Barski A, Pregizer S, Shen HC, Arasheben A, Neilson JJ, Frenkel B, Coetzee GA.
    Prostate; 2007 Sep 15; 67(13):1371-83. PubMed ID: 17624924
    [Abstract] [Full Text] [Related]

  • 22. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
    Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, Zhau HE, Chung LW.
    Prostate; 2007 May 15; 67(7):722-31. PubMed ID: 17342749
    [Abstract] [Full Text] [Related]

  • 23. Ectopic expression of neurotrophic peptide derived from saposin C increases proliferation and upregulates androgen receptor expression and transcriptional activity in human prostate cancer cells.
    Ding Y, Yuan HQ, Kong F, Hu XY, Ren K, Cai J, Wang XL, Young CY.
    Asian J Androl; 2007 Sep 15; 9(5):601-9. PubMed ID: 17712477
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells.
    Church DR, Lee E, Thompson TA, Basu HS, Ripple MO, Ariazi EA, Wilding G.
    Prostate; 2005 May 01; 63(2):155-68. PubMed ID: 15486991
    [Abstract] [Full Text] [Related]

  • 29. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 30. Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells.
    Hara T, Kouno J, Nakamura K, Kusaka M, Yamaoka M.
    Prostate; 2005 Nov 01; 65(3):268-75. PubMed ID: 16015592
    [Abstract] [Full Text] [Related]

  • 31. Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells.
    Eder IE, Haag P, Basik M, Mousses S, Bektic J, Bartsch G, Klocker H.
    Mol Carcinog; 2003 Aug 01; 37(4):181-91. PubMed ID: 12891627
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
    Wang LG, Ossowski L, Ferrari AC.
    Oncogene; 2004 Jul 01; 23(30):5175-84. PubMed ID: 15156193
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y, Mizokami A, Miwa S, Koshida K, Namiki M.
    Int J Urol; 2007 Mar 30; 14(3):233-9. PubMed ID: 17430262
    [Abstract] [Full Text] [Related]

  • 40. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T.
    Cancer Invest; 2007 Feb 30; 25(1):32-7. PubMed ID: 17364555
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.